HIV disclosure and stigma among women living with HIV in Denmark by Wessman, Maria et al.
Syddansk Universitet
HIV disclosure and stigma among women living with HIV in Denmark
Wessman, Maria; Thorsteinsson, Kristina; Storgaard, Merete; Rønsholt, Frederikke
Falkencrone; Johansen, Isik Somuncu; Pedersen, Gitte; Nielsen, Lars N; Wies, Nina;
Katzenstein, Terese L; Lebech, Anne-Mette K
Published in:
Journal of virus eradication
Publication date:
2017
Document version
Publisher's PDF, also known as Version of record
Document license
CC BY-NC-ND
Citation for pulished version (APA):
Wessman, M., Thorsteinsson, K., Storgaard, M., Rønsholt, F. F., Johansen, I. S., Pedersen, G., ... Lebech, A-M.
K. (2017). HIV disclosure and stigma among women living with HIV in Denmark. Journal of virus eradication,
3(3), 140-144.
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 15. Oct. 2017
HIV disclosure and stigma among women living with
HIV in Denmark
Maria Wessman1§*, Kristina Thorsteinsson1§, Merete Storgaard2, Frederikke F Rönsholt3, Isik S Johansen4, Gitte Pedersen5,
Lars N Nielsen6, Nina Wies1,7, Terese L Katzenstein3,7 and Anne-Mette Lebech1,7
1 Department of Infectious Diseases, Copenhagen University Hospital Hvidovre, Denmark
2 Department of Infectious Diseases, Aarhus University Hospital, Denmark
3 Department of Infectious Diseases, Copenhagen University Hospital, Denmark
4 Department of Infectious Diseases, Odense University Hospital, Denmark
5 Department of Infectious Diseases, Aalborg University Hospital, Denmark
6 Department of Lung and Infectious Diseases, Nordsjællands Hospital, Denmark
7 Department of Clinical Medicine, University of Copenhagen, Denmark
§ Co first authors
Abstract
Objective: To identify disclosure, stigma and predictors of non-disclosure among women living with HIV in Denmark.
Methods: A questionnaire study of women living with HIV in Denmark was performed. The enrolment period was from
February 2013 to March 2014. Logistic regression was used to estimate predictors of non-disclosure.
Results: A total of 234 participants were included. The majority (94%) had disclosed their HIV status to at least one
person outside their healthcare environment, although 29% had disclosed to fewer than three people. Confidantes were
mostly partners (96%), siblings (63%), friends (63%) and children (41%). The primary reason for non-disclosure was a
feeling that it did not concern others (55%), although reactions upon disclosure were mainly positive in 53%. Predictors
of non-disclosure were being of black or Asian ethnicity. Following their HIV diagnosis, 40% no longer dared to have
sex, 40% felt isolated and 23% felt that others were afraid and kept a physical distance. In contrast, after disclosure
75% felt better at taking decisions about life and 50% were in closer contact with family and friends.
Conclusion: Almost one-third of participants disclosed their HIV diagnosis to fewer than three people and black or Asian
ethnicity predicted non-disclosure. HIV-related stigma regarding sex and contact with others is still highly prevalent; however,
reactions to disclosure were mainly positive and associated with secondary positive gains. We strongly urge healthcare
professionals to initiate a dialogue regarding stigma and disclosure with women living with HIV with a view to increasing
disclosure and minimising stigmatisation in this vulnerable population.
Keywords: HIV, women, disclosure, stigma, black or Asian ethnicity
Introduction
In 2015, 37 million people were living with HIV globally, 51% of
whom were women [1]. Within the field of HIV research, there
is a profound under-representation of issues relating to women‘s
health [2] including clinical trials on antiretroviral therapy (ART)
[3], sexual and reproductive health, and ageing and psychological
well-being [2,4].
One of the key obstacles to HIV treatment, prevention and care
is stigma, and most women living with HIV suffer or fear
stigmatisation [5–7]. However, in a national Danish survey from
2007 the majority of people living with HIV (PLWH) experienced
mostly positive reactions when disclosing their HIV status [8].
HIV stigma is typically divided into three aspects: perceived,
experienced or enacted, and internalised stigma [9–11]. Perceived
stigma is the awareness among PLWH of negative public attitudes;
experienced or enacted stigma includes acts of discrimination
towards PLWH; and internalised stigma is the negative belief and
feeling towards oneself and HIV.
This study aimed to evaluate disclosure and stigma among women
living with HIV in Denmark – a setting where medical care and
ART is provided free of charge with a majority of PLWH having
fully suppressed plasma viral load [12] and living a ‘close to normal’
life. We further assessed predictors of non-disclosure.
Methods
Setting
Denmark has a total population of 5.6 million [13], 5000 of whom
are living with HIV and of these, 1400 are women [14].
The SHADE cohort
The study on HIV, cervical abnormalities and infections in women
in Denmark (SHADE), is a multicentre, prospective cohort study
of women living with HIV in Denmark attending care for acquired
HIV [15]. Women living with HIV, ≥18 years of age, were enrolled
from six outpatient clinics in Denmark and followed up after 6,
12 and 24 months. Exclusion criteria were pregnancy and/or
alcohol/drug use, for the potent to prevent adherence to the
protocol.
Questionnaire
Between February 2013 and March 2014, patients completed a
paper-based questionnaire, containing nine questions regarding
personal income, education, stigma and disclosure. The
questionnaire was validated for the Danish Living Condition Survey
in 2007 [8]. One question regarding personal income was
incorrectly answered by the majority of participants and, therefore,
excluded. Double manual data entry was performed, using the
EpiData Entry program [16].
Registration
The Civil Registration System
The Civil Registration System is a national registry of all residents
in Denmark [17]. At birth or immigration, a 10-digit personal
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identification number is assigned to each individual, which was
used to link to the Danish HIV Cohort Study and the SHADE
cohort.
Danish HIV Cohort Study
We obtained HIV characteristics and demographics from the Danish
HIV Cohort Study, which is a prospective, observational, national,
multicentre cohort study of all PLWH seen at Danish HIV clinics
since 1 January 1995 [12].
Ethical statement
The study was approved by the Danish Data Protection Agency
(2015-231-0126, 2012-58-0004 and 2012-41-0005) and the
Danish Regional Committee on Health Research Ethics (H-3-2010-
119 and H-2-2014-102).
Statistical analysis
Categorical variables were reported as counts and percentages and
compared by chi-squared tests or Fisher‘s exact tests. Continuous
variables were summarised as median and interquartile ranges and
compared using the Wilcoxon rank-sum test. Univariate and
multivariate logistic regression analysis was performed to identify
predictors of non-disclosure (defined as disclosure to fewer than
three people). Odds ratios and 95% confidence intervals were
estimated and adjusted for six candidate predictor variables chosen
a priori: age at inclusion (<40 vs ≥40 years of age); ethnicity; latest
viral load (<40 vs ≥40 copies/mL); latest CD4 cell count (<350
vs ≥350 cells/μL); time since diagnosis (<10 vs ≥10 years); and
educational level (<3 years vs ≥3 years after elementary school).
To control for repeated testing, a combined P-value was estimated
for the ethnicity variable spending more than one degree of
freedom in the logistic regression analysis. Individuals with missing
explanatory values were excluded from the multivariate regression
analyses. The validity of the model was tested using the Hosmer–
Lemeshow goodness-of-fit test. SAS statistical software version
9.3 (SAS Institute Inc, NC, USA) was used for data analysis and
P<0.05 (two-sided) was considered statistically significant.
Results
Baseline characteristics
A total of 234 of the 334 women living with HIV in the SHADE
study attended the 24-month follow-up (median age was 44 years
and median HIV duration was 13 years). Participants were
predominantly of white (45%) or black ethnicity (40%) and mostly
acquired HIV in Denmark (40%) or Africa (41%). Approximately
80% had a CD4 cell count of >350 cells/μL and the majority (86%)
was on ART with an undetectable viral load (<40 copies/mL).
Elementary school, which finishes at age 15, was the highest
educational level achieved by 24% of the participants (Table 1).
Disclosure
Almost all (93.6%) participants had disclosed their HIV status to
at least one person (outside the healthcare profession), 34% had
disclosed to more than 10 people. However, 6.4% had not
disclosed to anyone (Table 2). The participants mostly confided
in partners (96%), siblings (63%), friends (63%) and their own
children (41%). Reasons for non-disclosure were mainly ‘a feeling
that it does not concern others’ (55%), ‘not wanting to be seen
as HIV positive’ (46%), and ‘not wanting people to feel sad’ (42%).
The majority (88%) had not disclosed their HIV status to people
at a current place of work. More than half (53%) of the
participants had mainly experienced positive reactions upon
disclosure. Black or Asian ethnicities were predictors of non-
disclosure (Table 3). The Hosmer–Lemeshow goodness-of-fit tests
demonstrated sufficient fit (P=0.087, P=0.052).
Stigma
Data from questions about how life and relationships with others
had been affected by an HIV disclosure are shown in Table 4.
Notably, 40% (total of ‘large’, ‘some’ and ‘small’ extents) of women
Table 1. Baseline characteristics of 234 women, living with HIV in
Denmark. Median duration of HIV infection was 13 years
(IQR 8–18 years) and median age at inclusion was 44 years
(IQR 39–51)
Characteristic Study
participants
n (%)
Ethnicity
White 105 (45.1)
Asian 32 (13.7)
Black 94 (40.3)
Other 2 (0.9)
Missing 1
Place of HIV transmission
Denmark 84 (39.6)
Europe and USA 16 (7.6)
Africa 86 (40.6)
Asia 26 (12.3)
Other 0 (0)
Missing 22
Mode of transmission
Heterosexual 210 (92.5)
IDU 12 (5.3)
Other 5 (2.2)
Missing 7
Latest CD4 cell count (cells/μL)
<200 11 (5.0)
200–350 33 (14.9)
>350 177 (80.1)
Missing 13
ART
Yes 220 (94.0)
No 14 (6.0)
On ART with HIV RNA <40 copies/mL
Yes 182 (85.5)
No 31 (14.6)
Missing 7
Educational level
Primary or elementary school (age 15 years) 56 (23.9)
Semi-skilled worker training 13 (5.6)
Apprenticeship or basic vocational training 19 (8.1)
Other vocational training 42 (18.0)
Short course of higher education 26 (11.1)
Medium course of higher education 28 (12.0)
Long course of higher education 14 (6.0)
Missing 36
IDU: intravenous drug use; IQR: interquartile range; ART: antiretroviral
therapy.
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no longer ‘dared’ to have sex, 40% (total of
‘large’, ‘some’ and ‘small’ extents) felt isolated
and 23% thought that others were frightened
and kept a physical distance. Half of the
participants felt in closer contact with family
and friends after disclosure. Following
disclosure, 75% (total of ‘large’, ‘some’ and
‘small’ extents) of women felt more
empowered when making life decisions. We
stratified questions in Table 4 for disclosure
status and found that women who had
disclosed their HIV status experienced
significantly more contact with family and
friends and received more care and attention
from other people. No differences between
groups were found regarding the other
questions (data not shown).
Discussion
In this questionnaire study on disclosure and
stigma among women living with HIV in
Denmark who were enrolled into the SHADE
study, we found a low level of education in
24% of participants. The vast majority had
disclosed their HIV status to at least one person
and >50% of women were met with
predominantly positive reactions upon
disclosure. Furthermore, 75% felt that
disclosing improved their ability to make life
decisions. However, almost 40% of women felt
isolated and 40% no longer dared to have sex.
The low level of educational attainment is a
cause of concern, since a recent study found
that PLWH in Denmark with low educational
levels are at increased risk of lifestyle-related
mortality as compared to PLWH with higher
educational levels [18]. Elementary school is
the highest educational level achieved in only
8% of women from the general Danish
population (25–69 years) [13].
Disclosure
Disclosure is considered to be a gradual
process of revealing HIV status to an
increasing number of people over time [19].
Disclosure is associated with a better health
status, less social isolation and facilitates
access to social services and health support
[20–22]. The majority of participants had
disclosed their HIV status to at least one
person. We chose a cut-off of fewer than
three people, since confiding in only one or
two people reflects a fragile support network.
However, almost 30% had disclosed to fewer
than three people. Non-disclosure was
predicted by black and Asian ethnicity. This
was an expected finding, as it is a clear
impression in the outpatient clinics that
women of African descent experience higher
levels of perceived, experienced or enacted,
and internalised stigma, compared to their
white peers. In line with this, Stutterheim
et al. found that fear of stigma was a
profound reason of non-disclosure among
Table 2. Details of HIV disclosure in 234 women living with HIV in Denmark
Question Study
participants
n (%)
Disclosure overall (other than to healthcare professionals)
Have not told anyone? 13 (6.4)
1–2 persons 46 (22.6)
3–5 persons 45 (22.1)
6–10 persons 31 (15.1)
>10 persons 69 (33.8)
Missing 30
Other than to a healthcare professional, to whom have you disclosed?*
Spouse/partner 158 (96.3)
Parents 97 (52.7)
Brothers/sisters 116 (63.0)
Own children 71 (40.6)
Friends 118 (63.1)
Others 61 (35.1)
Reasons for non-disclosure to the above mentioned people*
You do not feel it concerns them 46 (54.8)
You are afraid they will blame you for being ill 18 (21.4)
It is a life-threatening illness and you do not want them to be sad 35 (41.7)
You are afraid that they will reject you 29 (34.5)
You do not wish to be seen as someone who is HIV positive 39 (46.4)
You are afraid of being talked about behind your back 33 (39.3)
You will tell him/her them at a later time 16 (19.0)
Other 8 (9.5)
HIV disclosure to people at current place of work*
Yes, everyone knows 9 (5.3)
Yes, most people know 5 (3.2)
Yes, some people know 12 (8.1)
Yes, your immediate superior knows 12 (8.7)
Yes, your immediate colleague knows 3 (2.2)
No 119 (87.5)
Reactions of colleagues when being told about the patient‘s HIV status
Very positive 13 (34.2)
Positive 8 (21.2)
Neutral 6 (15.8)
Negative 0 (0)
Very negative 1 (2.6)
Both positive and negative 4 (10.5)
Do not know 6 (15.8)
Missing 196
Reactions encountered within the last five years from people around
you when revealing the HIV status
Mainly positive reactions 84 (52.5)
Mainly negative reactions 11 (6.9)
Reactions have been mixed 40 (25.0)
Do not know 25 (15.6)
Missing 74
* More than one answer is possible; therefore, percentages add up to >100%.
ORIGINAL RESEARCH Journal of Virus Eradication 2017; 3: 140–144
142 M Wessman et al.
PLWH of African and Afro-Caribbean descent living in the
Netherlands [23,24]. Moreover, PLWH who have higher self-
perceived HIV-related stigma have been reported to be less likely
to disclose their HIV status to partners [25].
Stigma
Participants in the present study showed evidence of perceived
stigma, as more than two-thirds stated fear of rejection and of
being talked about as reasons for non-disclosure. Experienced
stigma was less frequent, although 7% of the participants had
encountered negative reactions upon disclosure and 23% felt that
others were frightened and kept a physical distance. However, after
disclosure, 75% felt better at making life decisions, which implies
that disclosure had a positive effect on the participants’ ability
to take action regarding life decisions. Internalised stigma was
present in almost 30% of participants who felt infectious and kept
Table 3. Predictors of disclosure of HIV infection in 205 women living with HIV in Denmark, unadjusted and adjusted for: age at inclusion; ethnicity;
latest HIV RNA; latest CD4 cell count; time since diagnosis; and educational level
Predictors of disclosure Disclosure to n≤2
persons (total number
of people=59)
n (%)
Disclosure to n>2
persons (total number
of people=146)
n (%)
Unadjusted
odds ratios
(95% CI)
P-value Adjusted
odds ratios*
(95% CI)
P-value
Age at inclusion (years)
<40 21 (35.6) 38 (26.2) 1.00 – 1.00 –
≥40 38 (64.4) 107 (73.8) 1.56 (0.81–2.98) 0.18 0.72 (0.31–1.66) 0.44
Missing 0 0
Ethnicity
White 13 (22.8) 84 (58.4) 1.00 – 1.00 –
Asian 16 (28.1) 13 (9.0) 0.12 (0.05–0.32) <0.0001 0.15 (0.05–0.47) 0.0011
Black 28 (49.1) 47 (32.6) 0.26 (0.12–0.55) 0.0004 0.34 (0.14–0.82) 0.017
Missing 2 1
Combined P-value <0.0001 0.0038
Latest viral load (copies/mL)
≥40 9 (17.3) 23 (16.5) 1.00 – 1.00 –
<40 43 (82.7) 116 (83.5) 1.06 (0.45–2.46) 0.90 1.28 (0.51–3.20) 0.60
Missing 7 6
Latest CD4 cell count (cells/μL)
<350 8 (15.4) 25 (17.9) 1.00 – 1.00 –
≥350 44 (84.6) 115 (82.1) 0.84 (0.35–1.99) 0.69 0.98 (0.38–2.50) 0.97
Missing 7 5
Time since diagnosis (years)
<10 29 (49.2) 50 (34.7) 1.00 – 1.00 -
≥10 30 (50.8) 94 (65.3) 1.82 (0.98–3.36) 0.057 1.43 (0.66–3.07) 0.36
Missing 0 1
Educational level
3 years after elementary school 40 (75.5) 88 (62.0) 1.00 – 1.00 –
>3 years after elementary school 13 (24.5) 54 (38.0) 1.89 (0.93–3.85) 0.080 1.24 (0.49–3.19) 0.65
Missing 6 3
* Validity of the model was tested using the Hosmer–Lemeshow goodness-of-fit test.
Table 4. Effect of disclosure on life and relations to others in 234 women living with HIV in Denmark
Have you experienced: To a large extent To some extent To a small extent Not at all Not sure Missing
n (%) n (%) n (%) n (%) n (%) n
More contact to family/friends? 31 (16.0) 38 (19.6) 28 (14.4) 81 (41.8) 16 (8.2) 40
More care/attention from others? 21 (10.9) 36 (18.8) 31 (16.1) 91 (47.4) 13 (6.8) 42
More consideration towards you? 11 (5.9) 20 (10.7) 28 (15.0) 104 (55.6) 24 (12.8) 47
That you are better at making life decisions? 59 (30.1) 67 (34.2) 21 (10.7) 36 (18.4) 13 (6.6) 38
That you feel isolated? 15 (7.7) 33 (16.9) 28 (14.3) 113 (58.0) 6 (3.1) 39
That others are afraid/ keep physical distance? 7 (3.7) 17 (8.9) 20 (10.3) 129 (67.2) 19 (9.9) 42
That you feel infectious/keep distance to others 13 (6.7) 21 (10.8) 23 (11.9) 127 (65.5) 10 (5.1) 40
That you no longer dare to have sex 22 (11.2) 24 (12.2) 34 (17.3) 109 (55.3) 8 (4.1) 37
More than one answer is possible, therefore, percentages add up to >100%.
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a distance from others and 40% who no longer ‘dared’ to have
sex. In the era of life-saving ART [26] and with recent studies
showing negligible or non-existent risk of HIV transmission for
PLWH who have chronically fully suppressed plasma viral load [27],
internalised stigma needs to be addressed globally in order to
decrease both public- and self-stigma, as it is the person living
with HIV‘s own belief that all the negative assumptions about HIV
and themselves are true [28].
The strengths of the present study include the well-described
cohort of women living with HIV from the data from the Danish
HIV Cohort Study. Furthermore, the use of a validated
questionnaire optimised results. An inborn weakness of many
questionnaire studies is that answers are self-reported and not
objectively verifiable. Data were collected 2013–2014; since then,
an improvement in societal perceptions towards a better
understanding of HIV and risks of transmission and thereby a
reduction in stigma in our patient group is possible. A potential
way of determining whether a change in stigma and disclosure
has happened would be to repeat the same study, and compare
results. We did not take gender-based violence into consideration
in this study, which might be a potentially significant issue in our
population, particularly when considering disclosure [29,30]. In
addition, age may have had an impact on the results, as we expect
that older women (who have been diagnosed for a longer period
of time than younger women) have experienced more stigma and
disclosure issues. They have experienced times when people living
with HIV were more stigmatised and discriminated against, than
perhaps have younger women. Finally, the exclusion of pregnant
women, and alcohol/drug using women may generate results that
underestimate the extent of disclosure and stigma among women
living with HIV in Denmark.
Conclusion
Perceived, experienced and internalised stigma still remains a
burden among women living with HIV in Denmark. Importantly,
once HIV status was disclosed, reactions were mainly positive and
associated with secondary positive gains. We, therefore, strongly
urge healthcare professionals to initiate a dialogue regarding stigma
and disclosure with women living with HIV and (if consented by
the patient) their networks, as a means to minimise stigmatisation
in this vulnerable population. Asking about patient experiences
of stigma would enable healthcare professionals to target help
and pair patients with mentors who have had similar experiences
in the same community. Furthermore, the potential for healthcare
professionals to offer education for family members or at the work
place, should be explored to increase an understanding of HIV
and thereby reduce stigmatisation in patients’ local communities.
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